9.31
2.53%
0.23
Dopo l'orario di chiusura:
9.39
0.08
+0.86%
Enanta Pharmaceuticals Inc Azioni (ENTA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
5.27%
17.05
|
18.00 | 18.93 | 18.89 | 17.80 |
Operating Expenses
|
5.80%
49.82
|
52.89 | 49.96 | 55.60 | 57.25 |
Interest Income/Expense |
25.52%
2.563
|
3.441 | 3.151 | 1.997 | - |
Benefits Costs and Expenses |
6.65%
48.57
|
52.03 | 48.45 | 53.74 | 55.41 |
Costs And Expenses |
5.80%
49.82
|
52.89 | 49.96 | 55.60 | 57.25 |
Depreciation and Amortization |
3.27%
0.621
|
0.642 | 0.669 | 0.651 | 0.54 |
Operating Income/Loss |
6.08%
-32.77
|
-34.89 | -31.03 | -36.71 | -39.45 |
Nonoperating Income/Loss |
45.39%
1.246
|
0.857 | 1.513 | 1.869 | 1.837 |
Income/Loss From Continuing Operations Before Tax |
7.37%
-31.52
|
-34.03 | -29.52 | -34.84 | -37.61 |
Income Tax Expense/Benefit |
41.64%
-0.363
|
-0.622 | -1.41 | 4.221 | 0.044 |
Income/Loss From Continuing Operations After Tax |
6.74%
-31.16
|
-33.41 | -28.11 | -39.06 | -37.66 |
Net Income/Loss
|
6.74%
-31.16
|
-33.41 | -28.11 | -39.06 | -37.66 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.37%
21.17
|
21.09 | -20.92 | 21.05 | 21.04 |
Diluted Average Shares |
0.37%
21.17
|
21.09 | -20.92 | 21.05 | 21.04 |
Basic Earnings Per Share |
6.96%
-1.47
|
-1.58 | -1.33 | -1.86 | -1.79 |
Diluted Earnings Per Share |
6.96%
-1.47
|
-1.58 | -1.33 | -1.86 | -1.79 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):